Esoterix Genetic Laboratories

The legal battle began last fall when LabCorp subsidiary Esoterix and Johns Hopkins University sued Myriad alleging infringement of four patents. 

Esoterix sued Myriad in September, claiming that its myRisk Hereditary Cancer panel and services directly infringe four patents it has exclusively licensed.

NEW YORK (GenomeWeb) – The recent lawsuit filed by Esoterix Genetic Laboratories against Qiagen over an alleged breached licensing agreement covering EGFR testing may be a message to other labs who have sold tests without a license.

NEW YORK (GenomeWeb) – LabCorp subsidiary Esoterix Genetic Laboratories is suing Qiagen in a US district court alleging that Qiagen breached a licensing agreement between the companies regarding EGFR genetic testing by offering it for commercial research and diagnostic purposes ahead of US Food a

Canon US Life Sciences has been awarded US Patent No. 8,409,848, "System and method for rapid thermal cycling."
Shulin Zeng, Kenton Hasson, Gregory Dale, and John Keady are named as inventors.

The Biological Research Center of the Hungarian Academy of Sciences and Glaxo Group Limited, a subsidiary of GlaxoSmithKline, have been jointly awarded US Patent No. 8,389,802, "Artificial chromosomes, uses thereof, and methods for preparing artificial chromosomes.

NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market on Thursday that a jury has found it guilty of infringing Enzo Biochem's patents and awarded Enzo $48.6 million.

NEW YORK (GenomeWeb News) – Esoterix Genetic Laboratories has filed a suit against Life Technologies alleging that the firm and its Applied Biosystems and Ion Torrent businesses infringe three patents held by Esoterix.

MUSC Foundation for Research Development, Esoterix Genetic Laboratories, and Roche Molecular Systems win US patents.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.